Uropathogens Based on Antibiotic Susceptibility

키워드

참고문헌 (26)

1. Ronald AR, "Urinary tract infection in adults: research priorities and strategies", Int J Antimicrob Agents, 17, pp.343~348 (2001)
2. Valiquette L, "Urinary tract infections in women", Can J Urol, 8(Suppl 1), pp.6~12 (2001)
3. Hooton TM, "Diagnosis and treatment of uncomplicated urinary tract infection", Infect Dis Clin North Am, 11, pp.551~581 (1997)
4. Kim ME, "Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2006", Int J Antimicrob Agents, 31(Suppl 1), pp.S15~S18 (2008)
5. Prabhu A, "Pyelonephritis: what are the present day causative organisms and antibiotic susceptibilities", Nephrology (Carlton), 18, pp.463~467 (2013)
6. 황병연, "서울 강서지역 1개 대학병원에서 성인 급성 신우신염의 원인균과 항생제 감수성", Infection and Chemotherapy, 35(5), pp.277~282 (2003), 대한감염학회
7. 이하정, "지역사회 획득 급성 신우신염의 원인균 및 ciprofloxacin 저항성에 대한 연구", Kidney Research and Clinical Practice, 27(6), pp.688~695 (2008), 대한신장학회
8. Ha US, "Acute bacterial prostatitis in Korea: clinical outcome, including symptoms, management, microbiology and course of disease", Int J Antimicrob Agents, 31(Suppl 1), pp.S96~S101 (2008)
9. Jemal A, "Global cancer statistics", CA Cancer J Clin, 61, pp.69~90 (2011)
10. Loeb S, "Complications after prostate biopsy: data from SEER-Medicare", J Urol, 186, pp.1830~1834 (2011)
11. Djavan B, "Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study", J Urol, 166, pp.856~860 (2001)
12. Aus G, "Infection after transrectal core biopsies of the prostate: risk factors and antibiotic prophylaxis", Br J Urol, 77, pp.851~855 (1996)
13. Rietbergen JB, "Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program", Urology, 49, pp.875~880 (1997)
14. Yu X, "Rapid and sensitive detection of fluoroquinolone-resistant Escherichia coli from urine samples using a genotyping DNA microarray", Int J Med Microbiol, 297, pp.417~429 (2007)
15. Tal R, "Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy", J Urol, 169, pp.1762~1765 (2003)
16. Otrock ZK, "Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon", Infect Control Hosp Epidemiol, 25, pp.873~877 (2004)
17. Nam RK, "Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy", J Urol, 183, pp.963~968 (2010)
18. Ozden E, "Incidence of acute prostatitis caused by extendedspectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy", Urology, 74, pp.119~123 (2009)
19. Liss MA, "Clinical and microbiological determinants of infection after transrectal prostate biopsy", Clin Infect Dis, 60, pp.979~987 (2015)
20. 방준호, "Microbiological Characteristics of Acute Prostatitis After Transrectal Prostate Biopsy", Korean J Urol, 54(2), pp.117~122 (2013), 대한비뇨기과학회
21. 이동섭, "Prevalence and Risk Factors for Extended Spectrum Beta-Lactamase-Producing Uropathogens in Patients with Urinary Tract Infection", Korean J Urol, 51(7), pp.492~497 (2010), 대한비뇨기과학회
22. Oteo J, "Emergence of imipenem resistance in clinical Escherichia coli during therapy", Int J Antimicrob Agents, 32, pp.534~537 (2008)
23. Rodríguez-Baño J, "Spanish Network for Research in Infectious Diseases (REIPI). Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis", Clin Infect Dis, 50, pp.40~48 (2010)
24. Rooney PJ, "Nursing homes as a reservoir of extendedspectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli", J Antimicrob Chemother, 64, pp.635~641 (2009)
25. Kelesidis T, "Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies", J Antimicrob Chemother, 62, pp.895~904 (2008)
26. Lu CT, "Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum betalactamase-producing Enterobacteriaceae", Int J Antimicrob Agents, 32(Suppl 3), pp.S179~S183 (2008)

관련 논문AI추천